These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11489676)

  • 1. Dystonia and parkinsonism.
    Jankovic J; Tintner R
    Parkinsonism Relat Disord; 2001 Oct; 8(2):109-21. PubMed ID: 11489676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pallidal Deep Brain Stimulation for the Treatment of Levodopa-Responsive Juvenile Dystonia and Parkinsonism Secondary to SPG11 Mutation.
    Ramirez-Zamora A; Gee L; Youn Y; Shin DS; Pilitsis JG
    JAMA Neurol; 2017 Jan; 74(1):127-128. PubMed ID: 27820618
    [No Abstract]   [Full Text] [Related]  

  • 3. [A patient with multiple system atrophy presenting prolonged levodopa-responsive parkinsonism and off-dystonia of the trunk].
    Nakanishi I; Hironishi M; Miwa H; Kondo T
    No To Shinkei; 2003 Jul; 55(7):605-8. PubMed ID: 12910995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral pallidal stimulation for x-linked dystonia parkinsonism.
    Wadia PM; Lim SY; Lozano AM; Adams JR; Poon YY; Torres Diaz CV; Moro E
    Arch Neurol; 2010 Aug; 67(8):1012-5. PubMed ID: 20697054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystonia and Parkinson's disease: What is the relationship?
    Shetty AS; Bhatia KP; Lang AE
    Neurobiol Dis; 2019 Dec; 132():104462. PubMed ID: 31078682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystonia in untreated parkinsonism.
    LeWitt PA; Burns RS; Newman RP
    Clin Neuropharmacol; 1986; 9(3):293-7. PubMed ID: 3719574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
    Krack P; Pollak P; Limousin P; Benazzouz A; Deuschl G; Benabid AL
    Brain; 1999 Jun; 122 ( Pt 6)():1133-46. PubMed ID: 10356065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystonia-plus syndromes.
    Asmus F; Gasser T
    Eur J Neurol; 2010 Jul; 17 Suppl 1():37-45. PubMed ID: 20590807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of dystonia in atypical parkinsonism.
    Godeiro-Junior C; Felício AC; Barsottini OG; Aguiar PM; Silva SM; Borges V; Ferraz HB
    Arq Neuropsiquiatr; 2008 Dec; 66(4):800-4. PubMed ID: 19099114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders.
    Lamberti P; De Mari M; Zenzola A; Aniello MS; Defazio G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S81-2. PubMed ID: 12548354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked dystonia ("Lubag") presenting predominantly with parkinsonism: a more benign phenotype?
    Evidente VG; Gwinn-Hardy K; Hardy J; Hernandez D; Singleton A
    Mov Disord; 2002 Jan; 17(1):200-2. PubMed ID: 11835466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early morning dystonia in Parkinson's disease.
    Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF
    Neurology; 1998 Jul; 51(1):283-5. PubMed ID: 9674823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication use in people with late stage Parkinson's disease and parkinsonism living at home and in institutional care in north-east England: A balance of symptoms and side-effects?
    Hand A; Gray WK; Oates LL; Woolford M; Todd A; Bale E; Jones C; Wood BH; Walker RW
    Parkinsonism Relat Disord; 2016 Nov; 32():120-123. PubMed ID: 27622968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P; Lenz FA; Chase TN
    Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
    [No Abstract]   [Full Text] [Related]  

  • 16. Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.
    de Souza A; de Souza RJ
    Parkinsonism Relat Disord; 2017 Oct; 43():120-121. PubMed ID: 28729089
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa can worsen tremor associated with dystonia.
    Hensman DJ; Bain PG
    Mov Disord; 2006 Oct; 21(10):1778-80. PubMed ID: 16856131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism.
    de Araújo DF; de Melo Neto AP; Oliveira ÍS; Brito BS; de Araújo IT; Barros IS; Lima JW; Horta WG; Gondim Fde A
    BMC Neurol; 2016 Aug; 16():139. PubMed ID: 27530902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystonia in atypical parkinsonian disorders.
    Marsili L; Bologna M; Kojovic M; Berardelli A; Espay AJ; Colosimo C
    Parkinsonism Relat Disord; 2019 Sep; 66():25-33. PubMed ID: 31443953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.